Immunology
Pipeline
About our Immunology efforts
Our R&D strategy is inspired by the courage of patients living with debilitating, life-limiting auto-immune conditions. We are taking bold steps to deliver scientific breakthroughs that target, repair and prevent these diseases. Specific areas of focus include inflammatory skin diseases and inflammatory bowel diseases such as Crohn’s Disease and Ulcerative Colitis.
Immunology
Systemic sclerosis
sGC activator
Avenciguat (BI 685509)
Immunology
Systemic Sclerosis
PDE4B inhibitor
Nerandomilast (BI 1015550)
Immunology
Hidradenitis suppurativa
IL36R antibody
Spesolimab (BI 655130)
Immunology
Netherton syndrome
IL36R antibody
Spesolimab (BI 655130)
Immunology
Pyoderma gangrenosum
IL36R antibody
Spesolimab (BI 655130)